Lithium Therapy, Bipolar Disorder, and Ion Channel Physiology
This community investigates the clinical management of bipolar disorder and the molecular mechanisms of ion transport, specifically focusing on lithium’s therapeutic effects, toxicity profiles, and its interaction with sodium and chloride homeostasis.
The research centers on lithium carbonate and lithium chloride as primary treatments for bipolar disorder, with extensive documentation of patient responses, chronic use, and toxicity management. A significant portion of the work examines the physiological underpinnings of these treatments, including the function of the Na+/K+-ATPase pump, chloride homeostasis, and the role of sodium valproate in epilepsy and mood stabilization. The literature also addresses the intersection of lithium exposure with neurological conditions such as Alzheimer’s disease and the impact of static magnetic fields on cellular processes. These studies frequently utilize rat models and human clinical data to map the relationship between ion channel dynamics and psychiatric outcomes.
The largest share of the community's output is found in lithium research, accounting for 3.0% of all lithium research, and 7,560 papers here. Sodium research contributes the second-largest share at 1.3%, followed by potassium at 1.1%.
The community comprises 17,417 papers, publishing most frequently in the Journal of Biological Chemistry, the American Journal of Psychiatry, and The Lancet.
Recent work continues to focus on lithium pharmacokinetics, toxicity management in the context of other medications, and the role of chloride homeostasis in neurological function.